PMID: 6990171Apr 1, 1980Paper

Dopaminergic control of serum potassium

Metabolism: Clinical and Experimental
M BevilacquaM Prandelli

Abstract

Metoclopramide, a dopaminergic inhibitor, injected in 9 normal volunteers, was followed by a prompt decrease of serum potassium (10--20 min; p less than 0.01) and by an increase of plasma aldosterone (p less than 0.01). Renin slightly increased at 45 min (p less than 0.05); insulin and cortisol did not show any significant increase. The urinary excretion of potassium rose after metoclopramide (p less than 0.05). A bolus of aldosterone (250 micrograms i.v.) in 4 normal subjects was not followed by any modification of serum potassium, but increased urinary potassium excretion (p less than 0.05); the injection of metoclopramide in two patients with an aldosterone-secreting adenoma of the adrenal and in one patient with Addison's disease induced a decrease of serum potassium in absence of any modification of plasma aldosterone. The decrease of serum potassium after metoclopramide is not explained by changes of aldosterone or insulin, considered the most important hormonal controls of potassium. The rapidity of potassium decrease implies a change of distribution of potassium between extra- and intracellular compartments, which, in turn, may stimulate aldosterone secretion. It is conceivable that the dopaminergic system has a role in...Continue Reading

References

Sep 1, 1977·The Journal of Physiology·T Clausen, J A Flatman
Dec 1, 1977·The Journal of Clinical Endocrinology and Metabolism·G NorbiatoC Moroni
Aug 1, 1976·Neuropharmacology·R Miller
Apr 1, 1975·The Journal of Clinical Investigation·R A DeFronzoP J Davis
Jul 1, 1975·The Journal of Clinical Endocrinology and Metabolism·T HimathongkamG H Williams
Jun 1, 1973·Archives of Internal Medicine·J P Knochel, M G White
May 1, 1970·The Journal of Clinical Endocrinology and Metabolism·D MayesC A Nugent
Mar 1, 1959·The Journal of Clinical Endocrinology and Metabolism·E J ROSSG W THORN
Jun 1, 1964·The Journal of Clinical Investigation·R H MCDONALDE P TUTTLE

❮ Previous
Next ❯

Citations

Jan 1, 1991·European Journal of Clinical Pharmacology·T M MacDonald
Jan 1, 1987·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·G MazzocchiG G Nussdorfer
Feb 29, 1984·Biochemical and Biophysical Research Communications·M BevilacquaG Norbiato
Jul 1, 1983·Journal of Steroid Biochemistry·G OpocherF Mantero
Jul 1, 1991·British Journal of Clinical Pharmacology·C C LangA D Struthers
May 1, 1984·Disease-a-month : DM·D C Batlle, N A Kurtzman
Oct 29, 1982·Biochemical and Biophysical Research Communications·M BevilacquaG Norbiato
Jan 1, 1984·Clinical and Experimental Hypertension. Part A, Theory and Practice·S Matsuda, N Aoki
Jan 1, 1981·Clinical and Experimental Hypertension : CHE·J R SowersM P Sambhi
Jan 1, 1988·Fundamental & Clinical Pharmacology·J L Cuche
Jan 1, 1983·Archiv für Psychiatrie und Nervenkrankheiten·D TerziivanovL Stika
Dec 1, 1981·Circulation Research·D J CampbellJ W Funder
Sep 1, 1982·Journal of Autonomic Pharmacology·M F Lokhandwala, R J Barrett
May 1, 1982·Clinical Endocrinology·T C GniadekJ Z Villareal
Mar 1, 1982·Journal of Endocrinological Investigation·F ManteroD Armanini
Mar 20, 2021·Documenta Ophthalmologica. Advances in Ophthalmology·Chihiro KaizukaTadashi Nakano

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addison Disease

Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Discover the latest research on Addison's disease here.